C

Cryo-Cell International Inc
F:ZCY

Watchlist Manager
Cryo-Cell International Inc
F:ZCY
Watchlist
Price: 2.66 EUR
Market Cap: €22.1m

Net Margin

-1.5%
Current
Improving
by 7.1%
vs 3-y average of -8.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-1.5%
=
Net Income
$-473.6k
/
Revenue
$31.7m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-1.5%
=
Net Income
€-473.6k
/
Revenue
$31.7m

Peer Comparison

Country Company Market Cap Net
Margin
US
Cryo-Cell International Inc
AMEX:CCEL
27.9m USD
Loading...
US
CVS Health Corp
NYSE:CVS
91.4B USD
Loading...
US
Cigna Group
XMUN:CGN
60.5B EUR
Loading...
US
Cigna Corp
NYSE:CI
72.1B USD
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
27B EUR
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
21.9B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
22.5B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
20.5B USD
Loading...
US
Guardant Health Inc
NASDAQ:GH
14.4B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR
Loading...
AU
Sonic Healthcare Ltd
ASX:SHL
11.1B AUD
Loading...

Market Distribution

In line with most companies in the United States of America
Percentile
39th
Based on 15 072 companies
39th percentile
-1.5%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Cryo-Cell International Inc
Glance View

Market Cap
22.1m EUR
Industry
Health Care

Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 83 full-time employees. The firm operates through three segments: The cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use; the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells, and the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives and other related healthcare professionals. The Company, in combination with its global affiliates, stores approximately 500,000 cord blood and cord tissue specimens around the world for the benefit of newborn babies and possibly other members of their families. Its processing and storage of specimens is handled from its facility in Oldsmar, Florida.

ZCY Intrinsic Value
2.79 EUR
Undervaluation 5%
Intrinsic Value
Price
C
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-1.5%
=
Net Income
$-473.6k
/
Revenue
$31.7m
What is Cryo-Cell International Inc's current Net Margin?

The current Net Margin for Cryo-Cell International Inc is -1.5%, which is above its 3-year median of -8.6%.

How has Net Margin changed over time?

Over the last 3 years, Cryo-Cell International Inc’s Net Margin has decreased from 4.3% to -1.5%. During this period, it reached a low of -31% on Feb 29, 2024 and a high of 9.1% on Nov 30, 2022.

Back to Top